Short: Active Biotech’s rights issue completed

Active Biotech has announced on Tuesday that following the end of the subscription period, the results of Active Biotech’s rights issue show that 6,643,426 shares, corresponding to approximately 96 percent of the shares offered, were subscribed for with subscription rights.

The remaining 272,596 shares have been subscribed for by the guarantor MGA Holding AB. Through the rights issue, Active Biotech receives proceeds amounting to approximately SEK 55 million, before issue expenses.

As a result of the rights issue Active Biotech’s share capital increases by approximately SEK 26,068,856.73 to approximately SEK 364,964,039.37 and the total number of shares and votes increases by 6,916,022 to 96,824,320.

Trading in the new shares on Nasdaq Stockholm is expected to commence on or about 27 December 2016.